p46, a novel natural killer cell-specific surface molecule that mediates cell activation

Journal of Experimental Medicine

Volumn 186, Issue 7, 1997, Pages 1129-1136

  Sivori, Simona ^a   Vitale, Massimo ^b   Morelli, Luigia ^a   Sanseverino, Lorenza ^a   Augugliaro, Raffaella ^b   Bottino, Cristina ^b   Moretta, Lorenzo ^a,b   Moretta, Alessandro ^a,c  

^a UNIVERSITY OF GENOA   (Italy)

^b CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; LYMPHOKINE; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CALCIUM MOBILIZATION; CELL DEATH; CELL SPECIFICITY; CROSS LINKING; CYTOFLUOROMETRY; CYTOLYSIS; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL;

EID: 0030809965     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.7.1129     Document Type: Article

References (41)

1. Herberman, R.B., M.E. Nunn, and D.H. Lavrin. 1976. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumours. I. Distribution of reactivity and specificity. Int. J. Cancer. 16:216-229.
2. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47:187-376.
3. Liao, N.S., M. Bix, M. Zijstra, R. Jaenisch, and D. Raulet. 1991. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science (Wash. DC). 253:199-202.
4. Karre, K. 1992. An unexpected petition for pardon. Curr. Biol. 2:613-616.
5. Moretta, L., E. Ciccone, M.C. Mingari, R. Biassoni, and A. Moretta. 1994. Human NK cells: origin, clonality, specificity and receptors. Adv. Immunol. 55:341-380.
6. Moretta, A., C. Bottino, M. Vitale, D. Pende, R. Biassoni, M.C. Mingari, and L. Moretta. 1996. Receptors for HLA-class I molecules in human Natural Killer cells. Annu. Rev. Immunol. 14:619-648.
7. Colonna, M., and J. Samaridis. 1995. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science (Wash. DC). 268:405-408.
8. Wagtmann, N., R. Biassoni, C. Cantoni, S. Verdiani, M.S. Malnati, M. Vitale, C. Bottino, L. Moretta, A. Moretta, and E.O. Long. 1995. Molecular clones of the p58 NK cell receptor reveal immunoglobulin related molecules with diversity in both the extra-and intracellular domains. Immunity. 2: 439-449.
9. D'Andrea, A., C. Chang, K. Franz-Bacon, T. McClanahan, J.H. Phillips, and L.L. Lanier. 1995. Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. J. Immunol. 155:2306-2310.
10. Moretta, A., M. Vitale, S. Sivori, C. Bottino, L. Morelli, R. Augugliaro, M. Barbaresi, D. Pende, E. Ciccone, M. Lopez-Botet, and L. Moretta. 1994. Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J. Exp. Med. 180:545-555.
11. Sivori, S., M. Vitale, C. Bottino, E. Marcenaro, L. Sanseverino, L., S. Parolini, L. Moretta, and A. Moretta. 1996. CD94 functions as a natural killer cell inhibitory receptor for different HLA-Class-I alleles. Identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. Eur. J. Immunol. 26:2487-2492.
12. Carretero, M., C. Cantoni, T. Bellón, C. Bottino, R. Biassoni, A. Rodríguez, J.J. Pérez-Villar, L. Moretta, A. Moretta, and M. López-Botet. 1997. The CD94 and NKG2-A C-type lectins covalently assemble to form a NK cell inhibitory receptor for HLA class I molecules. Eur. J. Immunol. 27:563-567.
13. Lazetic, S., C. Chang, J.P. Houchins, L.L. Lanier, and J.H. Phillips. 1996. Human Natural Killer cell receptors involved in MHC class I recognition are disulphide-linked heterodimers of CD94 and NKG2 subunits. J. Immunol. 157:4741-4745.
14. Vivier, E., M. Ackerly, N. Rochet, and P. Anderson. 1992. Structure and function of the CD16ζγ complex expressed on human natural killer cells. Int. J. Cancer. 7:11-14.
15. lck activation. J. Exp. Med. 176:1745-1750.
16. Bezouska, K., C. Yuen, J. O'Brien, R.A. Childs, W. Chai, A.M. Lawson, K. Drbal, A. Fiserova, M. Pospisil, and T. Feizi. 1994. Oligosaccharide ligands for NKR.P1 protein activate NK cells and cytotoxicity. Nature (Lond.). 372:150-157.
17. + natural killer cells. Role in cell activation and regulation of cytolytic function. J. Exp. Med. 171:695-714.
18. Moretta, A., G. Pantaleo, L. Moretta, M.C. Mingari, and J.C. Cerottini. 1983. Direct demonstration of the clonogenic potential of every human peripheral blood T cells. Clonal analysis of HLA-DR expression and cytolytic activity. J. Exp. Med. 157:743-754.
19. Bottino, C., S. Sivori, M. Vitale, C. Cantoni, M. Falco, D. Pende, L. Morelli, R. Augugliaro, G.P. Semenzato, R. Biassoni, et al. 1996. A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human Natural Killer cells and induces both triggering of cell functions and proliferation. Eur. J. Immunol. 26: 1816-1824.
20. Lanier, L.L., J.J. Ruitenberg, and J.H. Phillips. 1988. Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes. J. Immunol. 141:3478-3485.
21. Moretta, A., S. Sivori, M. Vitale, D. Pende, L. Morelli, R. Augugliaro, C. Bottino, and L. Moretta. 1995. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J. Exp. Med. 182:875-884.
22. Lanier, L.L., A.M. Le, C.I. Civin, M.R. Loken, and J.H. Phillips. 1986. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J. Immunol. 136:4480-4486.
23. Moretta, A., M. Vitale, C. Bottino, A.M. Orengo, L. Morelli, R. Augugliaro, M. Barbaresi, E. Ciccone, and L. Moretta. 1993. P58 molecules as putative receptors for MHC class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J. Exp. Med. 178: 597-604.
24. Vitale, M., S. Sivori, D. Pende, R. Augugliaro, C. Di Donato, A. Amoroso, M. Malnati, C. Bottino, L. Moretta, and A. Moretta. 1996. Physical and functional independency of p70 and p58 cell receptors for HLA-class I. Their role in the definition of different groups of alloreactive NK cell clones. Proc. Natl. Acad. Sci. USA. 93:1453-1457.
25. Litwin, V., J.E. Gumperz, P. Parham, J.H. Phillips, and L.L. Lanier. 1994. NKB1: a Natural Killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J. Exp. Med. 180:537-543.
26. Lanier, L.L., J. Phillips, J. Hackett, M. Tutt, and V. Kumar. 1986. Natural killer cells: definition of a cell type rather than a function. J. Immunol. 137:2375-2380.
27. Mingari, M.C., C. Vitale, A. Cambiaggi, F. Schiavetti, G. Melioli, S. Ferrini, and A. Poggi. 1995. Cytolytic T lymphocytes displaying natural killer (NK)-like activity. Expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. Int. Immunol. 7: 697-703.
28. + cells in response to the toxic shock syndrome toxin-1 (TSST-1) and their deletion upon secondary stimulation. Int. Immunol. 8: 203-209.
29. Phillips, J.H., J.E. Gumperz, P. Parham, and L.L. Lanier. 1995. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptor on T lymphocytes. Science (Wash. DC). 128:403-405.
30. Blery, M., J. Delon, A. Trautmann, R. Biassoni, L. Moretta. P. Chavrier, A. Moretta, M. Daeron, and E. Vivier. 1997. Inhibition of ITAM-dependent cell degranulation by killer cell MHC receptors. J. Biol. Chem. 272:8989-8996.
31. Biassoni, R., C. Cantoni, M. Falco, S. Verdiani, C. Bottino, M. Vitale, R. Conte, A. Poggi, A. Moretta, and L. Moretta. 1996. The HLA-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J. Exp. Med. 183:645-650.
32. Bolhuis, R.L., R.C. Roozemond, and R.J. Van de Griend. 1986. Induction and blocking of cytolysis in CD2+, CD3-NK and CD2+, CD34+ cytotoxic T lymphocytes via CD2 50 kD sheep erythrocyte receptor. J. Immunol. 136:3939-3944.
33. Moretta, A., A. Poggi, D. Pende, G. Tripodi, A.M. Orengo, N. Pella, R. Augugliaro, C. Bottino, E. Ciccone, and L. Moretta. 1991. CD69-mediated pathway of lymphocyte activation. Anti-CD69 mAbs trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing TCR-α/β. J. Exp. Med. 174: 1393-1398.
34. Moretta, A., C. Bottino, G. Tripodi, M. Vitale, D. Pende, L. Morelli, R. Augugliaro, M. Barbaresi, E. Ciccone, R. Millo, and L. Moretta. 1992. Novel surface molecules involved in human NK cell activation and triggering of the lytic machinery. Int. J. Cancer. 7:6-10.
35. Valiante, N.M., and G. Trinchieri. 1993. Identification of a novel signal transduction surface molecules on human cytotoxic lymphocytes. J. Exp. Med. 178:1397-1406.
36. Ryan, J.C., E.C. Niemi, M.C. Nakamura, and W.E. Seaman. 1995. NKR-P1 is a target-specific receptor that activates Natural Killer cell cytotoxicity. J. Exp. Med. 181:1911-1915.
37. Seaman, W.E., E.C. Niemi, M.R. Stark, R.D. Goldfien, A.S. Pollock, and J.B. Imboden. 1991. Molecular cloning of gp42, a cell-surface molecule that is selectively induced on rat natural killer cells by interleukin 2: glycolipid membrane anchoring and capacity for transmembrane signaling. J. Exp. Med. 173:251-260.
38. Chambers, B.J., M. Salcedo, and H.G. Ljiunggren. 1996. Triggering of natural killer cells by the costimulatory molecule CD80 (B7.1). Immunity. 5:311-317.
39. Mason, L.H., S.K. Anderson, W.M. Yokoyama, H.R.C. Smith, R. Winkler-Pickett, and J.R. Ortaldo. 1996. The Ly-49D receptor activates murine natural killer cells. J. Exp. Med. 184:2119-2128.
40. Hersey, P., and R. Bolhuis. 1987. "Nonspecific" MHC-unrestricted killer cells and their receptors. Immunol. Today. 8: 233-239.
41. Lanier, L.L., and J.H. Phillips. 1992. Triggering structures on NK cells. In Cytotoxic Cells: Generation, Recognition, Effector Functions, and Methods. M. Sitkovsky and P. Henkart, editors. Birkhauser Press, Boston, MA. 84-95.